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Abstract
Background: Bronchiolitis is the most common reason for infants under one year of age to be hospitalised.
Despite management being well defined with high quality evidence of no efficacy for salbutamol, adrenaline,
glucocorticoids, antibiotics or chest x-rays, substantial variation in practice occurs. Understanding factors that
influence practice variation is vital in order to tailor knowledge translation interventions to improve practice. This
study explores factors influencing the uptake of five evidence-based guideline recommendations using the
Theoretical Domains Framework.
Methods: Semi-structured interviews were undertaken with clinicians in emergency departments and paediatric
inpatient areas across Australia and New Zealand exploring current practice, and factors that influence this, based
on the Theoretical Domains Framework. Interview transcripts were coded using thematic content analysis.
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Results: Between July and October 2016, 20 clinicians (12 doctors, 8 nurses) were interviewed. Most clinicians believed
chest x-rays were not indicated and caused radiation exposure (beliefs about consequences). However, in practice their
decisions were influenced by concerns about misdiagnosis, severity of illness, lack of experience (knowledge) and
confidence in managing infants with bronchiolitis (skills), and parental pressure influencing practice (social influences).
Some senior clinicians believed trialling salbutamol might be of benefit for some infants (beliefs about consequences) but
others strongly discounted this, believing salbutamol to be ineffective, with high quality evidence supporting this
(knowledge). Most were concerned about antibiotic resistance and did not believe in antibiotic use in infants with
bronchiolitis (beliefs about consequences) but experienced pressure from parents to prescribe (social influences).
Glucocorticoid use was generally believed to be of no benefit (knowledge) with concerns surrounding frequency of use
in primary care, and parental pressure (social influences). Nurse’s reinforced evidence-based management of bronchiolitis
with junior clinicians (social/professional role and identity). Regular turnover of medical staff, a lack of ‘paediatric confident’
nurses and doctors, reduced senior medical coverage after hours, and time pressure in emergency departments were
factors influencing practice (environmental context and resources).
Conclusions: Factors influencing the management of infants with bronchiolitis in the acute care period were identified
using the Theoretical Domains Framework. These factors will inform the development of tailored knowledge translation
interventions.
Keywords: Bronchiolitis, Acute care, Emergency department, Paediatric, Clinical guideline, Evidence-based practice,
Theoretical domains framework
Background
Bronchiolitis is a common condition affecting infants
less than 1 year of age, with presentations to small rural
hospitals as well as large tertiary paediatric centres [1–
3]. It is the most common reason for admission to hos-
pital for infants aged less than 1 year. In New Zealand,
there are > 70 admissions/1000 infants with bronchiolitis
hospitalisation rates increasing year on year [4]. Māori
(relative risk (RR) 3.0), Pacific (RR 4.3), and those infants
living in the most deprived quintile (RR 4.7) are at most
risk [5]. In Australia, bronchiolitis accounts for 56% of
all admissions of infants aged less than 1 year [6]. Health
care expenditure for bronchiolitis is predominantly con-
fined to inpatient management of admitted patients,
with estimates that in the United States alone this cost is
US$1.7bn [7–9] accounting for approximately 100,000
infants admissions annually [8].
Management of bronchiolitis is well defined [7, 10, 11]
and necessitates supportive care; respiratory support,
supplemental hydration [12, 13] with medical and nurs-
ing involvement. Current international guidelines, [14–
16] including a recent evidence-based guideline from
Australia and New Zealand (Australasian Bronchiolitis
Guideline) [17, 18] recommend against the use of in-
haled salbutamol, inhaled adrenaline, oral glucocorti-
coids, antibiotics and chest x-rays (CXRs) as they are
considered ineffective for routine care of infants admit-
ted to hospital with bronchiolitis [12, 13, 17, 19–21].
Despite high quality evidence that these five therapies
and management processes are ineffective and associated
with harm, variation in practice continues. In Australia
and New Zealand, data from over 3000 presentations to
seven hospitals concluded that these five interventions
were used at least once in 27 to 48% of bronchiolitis ad-
missions [22, 23]. These data are consistent with inter-
national comparisons in North America, the United
Kingdom and Europe [24] and highlight the gap between
evidence-base and clinical practice.
There is little understanding of what works to improve
clinical practice in paediatric emergency medicine
(PEM) as evidence for effective dissemination and imple-
mentation methods in this setting is limited [25, 26].
What is clear from the knowledge translation (KT) lit-
erature is that interventions are more likely to be effect-
ive if theory is used in the development process. This
allows the targeting of causal determinants of behaviour
and facilitates an understanding of what works, for
whom, and under what conditions, with resulting inter-
ventions then “tailored and theory informed” [27–29].
The Theoretical Domains Framework (TDF) [30, 31]
has been designed to incorporate a wide range of theor-
ies relevant to behaviour change for use in implementa-
tion research. The TDF has a comprehensive structure
of 14 theoretical domains from 33 behaviour change the-
ories and 128 constructs. The framework has demon-
strated strong explanatory and predictive powers across
a number of healthcare settings and is particularly help-
ful when selecting interventions to improve practice
change. This framework has been successfully trialled in
the Australian ED environment to understand factors in-
fluencing the management of mild traumatic brain injury
in adults and guide intervention development [32, 33]. A
subsequent cluster randomised controlled trial of this
intervention resulted in improvement in the uptake of
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practice recommendations [34]. The TDF has also been
used to develop implementation interventions in the
acute care setting of stroke management [35, 36]. For
these reasons, this framework was considered appropri-
ate to use to develop interventions aiming to reduce the
evidence-practice gap in bronchiolitis management in
Australia and New Zealand.
The aim of this study was to explore factors identified
by ED and paediatric inpatient clinicians that may influ-
ence the uptake of five key evidence-based recommenda-
tions from the Australasian Bronchiolitis Guideline [17]
(see Table 1). Secondary aims sought to identify key dif-
ferences in influencing factors regarding location of hos-
pitals (metropolitan, regional) and seniority (senior,
junior) of clinicians (medical, nursing). Findings from
this study will be used to develop a targeted, theory and
evidence informed intervention aiming to reduce un-
necessary use of therapies in the care of infants with
bronchiolitis in Australian and New Zealand hospitals.
Evaluation of the intervention will be assessed through a
cluster randomised controlled trial, the protocol of
which is reported separately [37].
Methods
Study design
Qualitative study using in-depth, semi-structured
interviews.
Participants and sampling
Clinicians were eligible for inclusion if they were on an
active practice roster working in either the ED or paedi-
atric inpatient areas, in Australia and New Zealand as a
doctor or nurse with responsibility for the medical and
nursing management of infants with bronchiolitis. There
were no exclusion criteria. We used a stratified purpose-
ful sampling strategy from a range of metropolitan and
regional hospitals who were part of the Paediatric Re-
search in Emergency Departments International Collab-
orative (PREDICT) network, as well as sampling of
junior and senior medical and nursing clinicians, in
order to reduce selection bias. The objective was to re-
cruit from four hospitals reflective of the range of
hospitals where infants receive paediatric care across
Australia and New Zealand; from two countries
(Australia and New Zealand) and from two settings
(metropolitan hospitals/tertiary provider of paediatric
care with a paediatric ED and regional hospitals/second-
ary provider of paediatric care with a mixed adult/paedi-
atric ED).
No incentives were provided to participants. Sampling
continued until saturation of the data were reached, with
the stopping criteria tested after the third and then each
subsequent interview until there were three successive
interviews with no new material identified [38].
Recruitment
The clinical director of either the EDs or paediatric in-
patient area was initially approached to confirm that
their hospital would agree to take part in the study. An
invitation letter was emailed to clinical directors of both
ED and paediatric inpatient areas including a participant
information sheet and consent form. The clinical direc-
tors, together with nursing leads, at each site forwarded
study documentation to suitable medical and nursing
staff for participation in the study. Interested individuals
were invited to contact the research staff directly so that
questions could be answered by phone or email. Partici-
pants opted into the study through completion of a con-
sent form and gave verbal confirmation at the start of
the interview.
Face-to-face interviews with clinicians were under-
taken at an agreed time and location within their hos-
pital. If face-to-face interviews were not possible
clinicians were invited to be interviewed by telephone.
Three researchers (LH, EJT, CW) conducted the inter-
views, with two researchers being present at each inter-
view. All interviews were undertaken in English and
were digitally recorded. LH is a paediatric emergency
nurse practitioner with extensive experience of man-
aging infants with bronchiolitis. EJT is a post-doctoral
implementation researcher who has completed qualita-
tive studies using clinician interviews such as this, and
CW is a research coordinator with a nursing
background.








Salbutamol A Strong Do not administer salbutamol
Antibiotics B Conditional Do not use antibiotics
Glucocorticoids B Strong Do not administer systemic or local glucocorticoids (nebulised, oral,
intramuscular or intravenous)
Adrenaline B Strong Do not administer adrenaline (nebulised, intramuscular or intravenous)
Chest x-ray D Conditional Chest x-ray is not routinely indicated
NHMRC National Health and Medical Research of Council
GRADE Grading of Recommendations, Assessment, Development and Evaluations
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Interview content
The interview guide consisted of two parts (see Add-
itional file 2: Interview schedule). First, broad questions
were asked about bronchiolitis management and vari-
ability in practice. Second, clinicians’ perspectives were
sought on why the five evidence-based bronchiolitis rec-
ommendations were being followed, or not. Their per-
ceptions of the factors influencing their colleagues’
decision to order therapies and interventions were ex-
plored. The structure of the interview guide was in-
formed by the TDF with questions formulated to
explore domains. Practicing PEM clinicians (SRD, EO,
FEB) and the research team reviewed and revised the
interview schedule, which was subsequently piloted with
a senior nurse and doctor not associated with the study.
These interviews were not analysed.
Data analysis
The interview recordings were de-identified and tran-
scribed verbatim. Checked transcripts were uploaded
into NVivo 11 qualitative data analysis Software (QSR
International Pty Ltd., London, United Kingdom) to
manage and facilitate the analysis.
Data were analysed using inductive thematic analysis
and an iterative process. Two researchers (LH/EJT) inde-
pendently reviewed the transcribed interview and open
coded text relevant to each of the recommended
practices and the factors influencing those practices. The
TDF offered an analytic framework to code these factors.
When text was relevant to more than one domain, it
was cross indexed. Coding was discussed by interviewers
after the first five interviews to ensure consistency. Dis-
crepancies were identified, discussed and consensus was
reached. Saliency analysis confirmed the degree to which
each code occurred, and implied importance (frequently
mentioned or deemed important by participants or re-
searchers) [39]. Important factors within a domain were
highlighted by verbatim quotations [40].
The Standards for Reporting Qualitative Research
(SRQR) has been followed and checklist completed (see
Additional file 1: SRQR checklist) [41].
Central ethics review and approval for the project was
undertaken in Australia and New Zealand (see Declara-
tions section for further details).
Results
Participants
Four hospitals were approached, all agreed to partici-
pate. Thematic saturation was reached at 20 inter-
views (see Table 2), conducted between July and
October 2016. Face-to-face interviews were conducted
with 17 clinicians and telephone interviews with
three. The median interview duration was 30 min with
a range of 20 to 49 min.
Table 2 Characteristics of participants




























No5 3 2 5
New Zealand
n = 14
3 Australia Metro Paediatric ED Yes 1 1 2
3 Australia Metro Paediatric inpatient
ward
Yes 2 1 3
4 Australia Regional Mixed adult/
paediatric ED
No5 0
4 Australia Regional Paediatric inpatient
ward
No5 1 1
Australia n = 6
TOTAL 10 2 2 6 20
1Level – Metropolitan/major city (metro) or Regional
2Area – Paediatric inpatient ward or Emergency Department (ED) (paediatric ED OR mixed adult and paediatric ED)
3Senior Medical Officer – Consultant Paediatrician or Emergency Physician (> 10 years post graduate experience)
4Senior registered nurse – nurse working in senior nursing position (> 10 years post graduate experience)
5Use local tertiary hospital’s guideline
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Each of the recommended practices from the Australa-
sian Bronchiolitis Guideline had its own patterns of in-
fluencing factors. Additional file 3: Tables S1 to S5 lists
the factors perceived to influence practices, arranged by
TDF domains and clinician group. Explanatory quota-
tions have been included to further describe clinician’s
beliefs. Minor changes to quotations have been made to
ensure readability with the clinicians intended statement
remaining unchanged and in italics. The following para-
graphs summarize our findings. Responses were consist-
ent across both countries.
Chest x-ray use in infants with bronchiolitis
The majority of clinicians did not see routine CXR as in-
dicated for infants with bronchiolitis.
Factors influencing practice
The key factors perceived to influence practice of perform-
ing a CXR in infants with bronchiolitis were predominantly
grouped within five domains: beliefs about consequences,
knowledge, skills, social influences, and environmental con-
text and resources (see Additional file 3: Table S1).
There were widely held concerns about the known
risks of radiation (beliefs about consequences).
What concerns you is if the child has been in eight
times for bronchiolitis and they’ve had six x-rays,
and you, kind of, think that’s getting unnecessary.
(Senior Medical Officer (SMO), Paediatric Inpa-
tients, Regional)
There were some who believed that as a CXR involved
only a small amount of radiation, it was not a problem
(beliefs about consequences).
They’re just doing extra things that are unnecessary
and costly and maybe just have a little bit of
morbidity in the sense you’ve given them a small
amount of radiation. (SMO, Paediatric Inpatients,
Metropolitan)
The majority of nurses and doctors expressed concerns
about missing an alternative diagnosis or, if an infant
was in significant respiratory distress, a CXR could be
justified and might assist in confirming the diagnosis
(beliefs about consequences).
I think they’re worried about deterioration. And I
think worried about whether a child should be on IV
antibiotics. (SMO, Paediatric ED, Metropolitan)
Both doctors and nurses stated that CXRs were more
likely to be undertaken by clinicians who had a lack of
knowledge and experience in caring for infants with
bronchiolitis (knowledge).
Yeah, I think it’s lack of knowledge and seniority,
really. The more junior you are, you, I guess, tend to
do more things, because you think it’s the right thing
to do and it might not be the right thing to do. (Se-
nior Registered Nurse, Paediatric ED, Metropolitan)
Several senior nurses and doctors perceived there was
often a lack of competence and confidence in caring for
infants with bronchiolitis which led to the increased use
of CXRs (skills).
Several clinicians considered that parental pressure
was a factor in CXRs being performed (social influ-
ences). Either they were expecting a CXR (e.g. had been
advised by their primary health care provider that one
would be completed in the ED) or that parents felt reas-
sured if a CXR was completed.
So there are parents that come in with expectations.
(Resident Medical Officer (SMO), Paediatric Inpa-
tients, Metropolitan)
Several environmental context and resource factors
were identified that were thought to influence a clinician’s
decision to order a CXR. In both metropolitan and re-
gional hospitals, time pressure to make decisions in ED
(all sites have government imposed ED length of stay tar-
gets of between 4 and 6 h), reduced after hours support
for junior medical staff, and turnover and rotations of staff
were thought to contribute to infants receiving a CXR.
A brand-new Senior House Officer who has only seen
a handful of bronchiolitis, who’s on overnight, who’s
got a baby who’s working [hard] and has a fever,
then I think that they will be more inclined to do an
x-ray. (SMO, Paediatric Inpatients, Regional)
Specific influencing factors for regional hospitals were
identified with more doctors being trained overseas
where practices differ, staff who were not paediatric
trained, and the challenge of distance to tertiary care
providers.
I suppose from a retrieval’s perspective, you really
want to make sure it’s bronch and nothing else. And
you’re not going to get a surprise on route as well.
(SMO, Paediatric Inpatients, Metropolitan)
Salbutamol use in infants with bronchiolitis
There was variability in the self-reported use of salbuta-
mol. Some clinicians stated they would not give it to an
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infant with bronchiolitis, while others stated they would
trial it on some. Senior and junior doctors shared both
perspectives.
Factors influencing practice
The key factors thought to influence clinicians’ decisions
on whether to use salbutamol in infants with bronchio-
litis centred on four key domains: beliefs about conse-
quences, knowledge, social/professional role and
identity, and social influences (see Additional file 3:
Table S2).
Senior doctors showed variation in their reported use
of salbutamol. Some saw benefits in using salbutamol in
infants with a history of atopy or those closer to 1 year
of age (beliefs about consequences). From personal ex-
perience, they felt it was worth trying if it enabled an in-
fant to be discharged home rather than be hospitalised.
If someone can be made better and go home, then
it’s worth trying. (SMO, Paediatric ED,
Metropolitan)
Some senior doctors indicated that having a new
guideline would not change their own practice in the
use of salbutamol and there was no harm in trialling it.
Others believed an evidence-based guideline stating
not to use salbutamol would be of benefit to guide prac-
tice for both junior and senior clinicians in metropolitan
and regional hospitals (knowledge). Additionally, being
aware of normal illness progression, and knowledge that
salbutamol is not effective, would guide practice
decisions.
Because most of us don’t at a more senior level [give
salbutamol], if we see a deteriorating bronchiolitis,
we’re more willing to accept that as progression of
the underlying condition, as opposed to lack of treat-
ment with salbutamol. (SMO, Paediatric Inpatients,
Metropolitan)
Nurses and doctors with a wide range of experience
levels perceived a lack of knowledge in regard to the evi-
dence for salbutamol use in infants with bronchiolitis.
If you are going to try a bronchodilator, why are you
doing this? And what’s the evidence behind it and
understanding the lack of evidence behind it, and
doing that in conjunction with a senior clinician.
(SMO, mixed adult/paediatric ED, Regional)
Some nurses felt that knowledge was a factor when jun-
ior doctors treated infants with bronchiolitis in the same
way they would an older child with viral induced wheeze
or asthma.
I think they are, kind of mixing the asthma/viral in-
duced wheeze with the bronchiolitis one; so we were
going by our experience with the patient whereas I
feel like sometimes they are drawing on experience
with something else. (Registered Nurse (RN), Paedi-
atric Inpatients, Metropolitan)
Senior nurses and doctors discussed the crucial role that
nurses have in guiding junior doctors’ practice and in
questioning their clinical decisions and treatments (so-
cial/professional role and identity).
And in fact, our nurses are one of the most influen-
tial group. Because they question the juniors; the
junior doctors. (SMO, Paediatric ED, Metropolitan)
There were mixed views from nurses in regard to ques-
tioning doctors’ orders for salbutamol. Most senior
nurses felt comfortable but there were times junior
nurses did not feel listened to.
There are so many children who are charted salbu-
tamol where the nursing staff are saying, “Look, this
child isn’t responsive” but then one of the medical
team will go and hear something completely different
from what the nurses hear, so they’ll say, “Yes, they
are partially responsive. You should continue.” So,
nursing staff will continue, but still not think it’s ef-
fective. (RN, Paediatric Inpatients, Metropolitan)
Nurses and doctors discussed pressure from both par-
ents and clinicians to trial salbutamol (social influences).
Parents had sometimes been given salbutamol for a pre-
vious episode of bronchiolitis, or in an older child with
wheeze, and believed it made a positive difference. Pres-
sure on clinicians came from wanting to do something
to help an infant, or pressure from other clinicians ques-
tioning whether they had tried salbutamol.
I think the commonest reason for its use, well, the
two things is people wanting to give them something,
so parental pressure and clinicians’ internal pressure
to give some kind of treatment for an illness that
there is actually no additional treatment for and
misunderstanding about the idea that it’s not actu-
ally salbutamol responsive wheeze. (SMO, mixed
adult/paediatric ED, Regional)
Antibiotic use in infants with bronchiolitis
The majority of clinicians stated they did not prescribe
antibiotics for infants with bronchiolitis, but noted they
saw many infants being given antibiotics by other
clinicians.
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Factors influencing practice
The key factors perceived to influence antibiotic use in
infants with bronchiolitis were grouped in three do-
mains: beliefs about consequences, social influences, and
knowledge (see Additional file 3: Table S3).
Amongst nurses and doctors there was a consistent
belief that there is no benefit in administering antibiotics
to infants with bronchiolitis. Most clinicians were com-
fortable giving advice to stop a course that had been
started. There were mixed beliefs about the conse-
quences of antibiotic use; the majority of clinicians felt
strongly about reducing antibiotic use due to increasing
concerns about antibiotic resistance, although some did
not share this concern (beliefs about consequences).
48 hours of antibiotics in terms of the big picture of
antibiotic resistance isn’t going to make that much of
a difference. (SMO, Paediatric ED, Metropolitan)
One senior doctor spoke of high antibiotic prescribing
for infants with bronchiolitis in his region, which he be-
lieved was due to a high bronchiectasis rate in the local
population.
We do have quite a high antibiotic prescribing rate
but we think that we’ve also got a high bronchiec-
tasis problem. So being too strict about it being just
viral, I might leave our high Māori deprivation,
smoke exposed kids to not being appropriately
treated for early bronchiectasis. (SMO, Paediatric In-
patients, Regional)
Doctors and nurses discussed the pressure they experi-
enced from parents who wanted antibiotics to be pre-
scribed, or if a course had started, to continue (social
influences).
I think they do [in regard to doctors having a concern
about the consequences of giving antibiotics] but they
are focusing on the short term as opposed to the long
term, so in the short term they’re keeping the family
happy. (RN, Paediatric Inpatients, Metropolitan)
Some clinicians perceived a lack of knowledge and
limited experience in the management of bronchiolitis
could result in a CXR being performed and antibiotics
subsequently being prescribed (knowledge).
Which is why so many children get treated with an-
tibiotics, I think. There’s concern that there’s not
quite enough wheeze. That leads to an x-ray. There’s
abnormalities on the x-ray. That leads to treatment
with antibiotics. (Senior RN, Paediatric Inpatients,
Metropolitan)
Glucocorticoid use in infants with bronchiolitis
The vast majority of clinicians reported that they did not
use glucocorticoids for infants with bronchiolitis, but did
see many infants who had been prescribed this by other
clinicians.
Factors influencing practice
The key factors identified that influenced clinicians in
regard to glucocorticoid use were grouped within six
domains: knowledge, beliefs about consequences,
beliefs about capabilities, social/professional role and
identity, environmental context and resources, and so-
cial influences (see Additional file 3: Table S4).
There was a widely held belief among clinicians that
there was no benefit to be gained from the use of gluco-
corticoids in infants with bronchiolitis. There was also a
concern about the possible consequences of glucocorti-
coids use (knowledge, beliefs about consequences).
So on a ‘primum non nocere’ principle that steroids
could actually predispose to immune suppression, I
saw one fatal pneumonia from recurrent courses of
Redipred prescribed to a baby that had barely
reached term, or not long past it. (SMO, Paediatric
Inpatients, Regional)
Several clinicians discussed the use of glucocorticoid in the
community and expressed concerns around repeated use.
I was very surprised by the high use of it in the com-
munity, you know, often the families were coming
and not only having had steroid but have a stash of
steroid at home and are using that. (SMO, Paediat-
ric Inpatients, Regional)
Because doctors believed there was no need to pre-
scribe glucocorticoids, they were comfortable in advis-
ing a family to stop a course that had been started
(belief about capabilities). They were conscious of the
need to discuss this in a manner that preserved the
existing relationship with a family’s primary health-
care provider (social/professional role and identity).
You need families to trust their General Practitioners. So
you don’t want to run them down and say, “This is ridicu-
lous, stop it”. (RMO, Paediatric ED, Metropolitan)
One clinician discussed how to approach stopping
glucocorticoids with a family, and the importance of
listening and acknowledging the family’s perspective.
I always sort of think, would you give this to your
own kids, would I take this myself? (SMO, Paediatric
Inpatients, Regional)
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Environmental context was an important factor for
some regional hospitals that had staff who had trained
and worked in countries where beliefs and practices in
the use of glucocorticoids differed (environmental con-
text and resources).
We’ve had quite a few American consultants come
through who have quite different opinions, so it’s ac-
tually quite difficult for our juniors. (SMO, mixed
adult/paediatric ED, Regional)
Several clinicians perceived there was pressure from
families to prescribe glucocorticoids (social influences)
and that this was often based on a family’s past
experience.
Especially if you’ve got a kid with recurrent bron-
chiolitis the parents will go “This is what works. This
is the only thing that’s worked in the past. We’ve
tried this and this; we always have to go to steroids
at the end of the day”. (RN, mixed adult/paediatric
ED, Regional)
Adrenaline use in infants with bronchiolitis
There was very limited discussion around the use of
adrenaline in uncomplicated bronchiolitis due to this
therapy being rarely used in Australian and New Zealand
hospitals except in peri-arrest of a critically unwell
infant.
General comments around caring for an infant with
bronchiolitis
Interviewers attempted to direct the interviews to the
five recommendations from the Australasian Bronchio-
litis Guideline as detailed previously (see Table 1) [17].
Throughout the interviews, many participants spoke
about more general issues and the challenges of caring
for infants with bronchiolitis. Given the frequency of
these views, they were considered important, and coded.
The key factors that influenced the overall care of in-
fants with bronchiolitis were: beliefs about conse-
quences, knowledge, social/professional role and
identity, environmental context and resources, and skills.
(see Additional file 3: Table S5).
There was a concern from clinicians that the infant
would deteriorate and they should be intervening (belief
about consequences).
This kid is looking quite sick, I should be doing
something. (SMO, Paediatric ED, Metropolitan)
There were very positive responses to the development
of an Australasian Bronchiolitis Guideline [17] with
doctors and nurses from ED, inpatient paediatrics,
metropolitan and regional hospitals believing that this
would improve the care of infants with bronchiolitis. Cli-
nicians said the guideline would increase overall
consistency of care across states and countries
(knowledge).
Once you have very clear protocol type guideline as
to what to do and when to do it, then it gives people
a recipe to follow and they’re more likely to follow it.
(SMO, Paediatric Inpatients, Metropolitan)
Nurses reported that a guideline would provide sound
evidence to support their discussions with doctors and
inform management.
Key differences in the management of bronchiolitis
due to location were discussed. Emergency clinicians
spoke of the challenges in mixed adult/paediatric EDs
and of feeling less confident in the care of infants, rela-
tive to adults (knowledge).
Concerns related to the recognition of illness, and se-
verity of illness, and undertaking procedures, such as
inserting a nasogastric tube in an infant. Doctors and
nurses highlighted the importance of positive relation-
ships between clinicians (social/professional role and
identity) and a willingness to seek advice.
It’s probably a bit of lack of knowledge and lack of
experience; you’ve not seen enough, you’re just wor-
ried. They can look quite bad and you are in a pos-
ition where you don’t really want to miss something,
although you’ve really got nothing to miss. (RMO,
Paediatric ED, Metropolitan)
Regional hospitals highlighted the challenges of distance and
time in transferring critically unwell infants, and suggested
this might influence care. For example, a CXR undertaken as
a routine investigation prior to transfer, which commonly oc-
curs (environmental context and resources).
It’s terrifying! (in response to “it must be quite stress-
ful at night?”). (RMO, Mixed ED, Regional)
Additionally, regional hospitals were more likely to have
locum or overseas trained staff with frequent rotations,
creating challenges in maintaining staff competencies in
line with best practice guidelines.
Role modelling by senior clinicians was highlighted as
a way of developing skills (skills); listening to how other
clinicians interacted with families and emulating this in
their own practice was described as helpful.
But I think we also under describe what we are
doing. Like I think honouring nursing care at its best,
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we do that insufficiently at times. So for example, I
think it should be phrased quite positively. We are
maintaining fluids and all those regimens. (SMO,
Paediatric Inpatients, Regional)
Many clinicians also discussed the increased use of high-
flow oxygen therapy and its place in the care of infants
with bronchiolitis.
Machines that go beep, and it looks impressive to the
family, and we have a real perception that it's one of
those. (SMO, Paediatric Inpatients, Regional)
Discussion
This study used the TDF to explore factors, real or per-
ceived, that influence the management of infants with
bronchiolitis in relation to CXR, salbutamol, antibiotics,
glucocorticoids and adrenaline. Despite wide variation in
clinical practice, we are not aware of any other study
that has investigated this issue. Five domains were iden-
tified as consistently important in four of the five inter-
ventions known to be of no benefit in the care of an
infant with bronchiolitis: beliefs about consequences,
knowledge, social/professional role and identity, environ-
mental context and resources, and skills. Using the TDF,
our study has generated knowledge and understanding
of what influences bronchiolitis management in Austra-
lian and New Zealand settings, and provides an ideal
platform to design interventions targeted to improve
practice. As practice variation occurs in other countries,
such as the United Kingdom, Canada and the United
States, while needing confirmation, these findings are
likely to have high relevance.
The domain of beliefs about consequences was con-
sistently found to be important, particularly in relation
to the use of CXR. Clinicians face a challenging task
when an infant with bronchiolitis presents in the acute
care setting – they are generally unknown to them, time
pressure is a feature of the ED environment, and the
clinician is concerned about missing a more serious
diagnosis. Major influencing factors are likely to be fear
of missing a pneumonia as well as the relative luxury of
being able to obtain a CXR in the ED [42]. Our inter-
views highlighted the belief that the frequency with
which CXRs are performed was primarily due to con-
cern about missing a more serious diagnosis, and believ-
ing a CXR would further assist in diagnosis. The
unnecessary use of CXR exposes infants to radiation, in-
creases financial cost, increases the time of medical care
[43] and increases unnecessary use of antibiotics [44].
Doctors and nurses of all levels of experience commonly
expressed concerns about radiation exposure and in-
appropriate antibiotic use. Implementation of an Austra-
lasian evidence-based bronchiolitis guideline provides
the ideal platform to improve clinicians’ knowledge of
bronchiolitis leading to confidence in diagnosis, reduced
fear of missing an alternative diagnosis such as pneumo-
nia, and improved bronchiolitis management.
It was reassuring that the majority of clinicians felt
comfortable to give advice to stop a course of antibiotics,
and were aware of the importance of managing this in a
way that maintained the existing relationship between
the family and primary care provider.
The second most common domain was around know-
ledge of bronchiolitis and its management. One of the
factors contributing to this may be that ED clinicians
deal with a broad spectrum of conditions, which pose
challenges in keeping up-to-date with current practice.
This was highlighted in a recent Australian study investi-
gating the evidence-based management of minor trau-
matic brain injury in EDs [32]. From our interviews,
there was a belief that some doctors and nurses lacked
confidence in managing sick infants in mixed adult/
paediatric EDs where the majority of patients presenting
are adults. This was an issue raised by both doctors and
nurses. Another issue related to junior doctors, was their
frequent rotations through specialties, and the import-
ance of knowledge development in the care of infants,
including those with bronchiolitis. Overall, there was a
common belief that all staff needed to be up-to-date
with current clinical guidelines with acknowledgement
of the challenge in achieving this. The consistently af-
firmative opinion of clinical guidelines from both nurses
and doctors is expected to positively influence the suc-
cessful implementation of the Australasian Bronchiolitis
Guideline aiming to improve the management of infants
with bronchiolitis.
Out of the five interventions known to be of no bene-
fit, salbutamol provided the most variation in clinicians’
responses. The belief that salbutamol was effective and
worth trialling on some infants was firmly held by some
senior doctors (ED and inpatient paediatrics; metropol-
itan and regional) who stated that a guideline would not
change their practice. In contrast, other senior doctors
felt equally as strongly about not administering salbuta-
mol, and welcomed a guideline that supported their be-
lief that salbutamol was not effective and shouldn’t be
used.
Social/professional role and identity and the import-
ance of collaborative care and clinician relationships was
also an important feature in the care of infants with
bronchiolitis. Nurses said they felt valued when asked
for advice on bronchiolitis management by their medical
colleagues, but some also expressed concern that their
clinical assessments were sometimes ignored, in particu-
lar in relation to the ineffectiveness of salbutamol. At
times junior doctors said they felt torn between prac-
ticing evidence-based medicine, and having a senior
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colleague advise them to the contrary. This mainly oc-
curred in regard to the use of salbutamol and CXR.
The social influences domain was evident in findings
from four clinical therapies: CXR, salbutamol, antibiotics
and glucocorticoids. Parental or care giver pressure to
“do something” when advocating for their sick infant by
either wanting medication or a CXR was highlighted.
Clinicians listened to the requests of families and at
times felt challenged by these interactions. Despite
knowing specific interventions were not advised, they
felt helpless just offering supportive care. Some junior
doctors felt strategies for discussing bronchiolitis with a
family would be helpful, with the focus being on the
value of supportive care, and the importance of minimis-
ing unnecessary interventions. All hospitals used either
their own local bronchiolitis family information sheet or
one from another hospital. Clinicians felt these to be of
value in reinforcing information given verbally, and help-
ing to reduce parent and caregiver stress.
A recent study conducted in Wales using multi-
faceted education (developed by the study authors) to
reduce investigations (CXR, naso-pharyngeal aspirate,
bloods, blood gas and urine) in infants with bronchio-
litis, reported a 21% decrease in their use nationally. Dir-
ectly approaching clinicians for feedback to improve the
bundle, as well as increasing involvement with the
multi-disciplinary team (doctors and nurses) was recom-
mended [45]. Additionally, Mittal et al reports a reduc-
tion in CXR, bronchodilator, glucocorticoid and
antibiotic use with the introduction of a clinical practice
guideline and multi-faceted education in the United
States (designed by a multi-disciplinary team from key
stakeholders of a Bronchiolitis Task Force) [46]. We sug-
gest that by specifically targeting those factors which all
clinicians believe lead to investigations and therapies be-
ing undertaken could lead to further improvement.
The findings from this qualitative study will be used to
guide the development of a tailored, theory informed KT
intervention aiming to reduce the use of the five
evidence-based therapies known to be of no benefit in
the management of infants with bronchiolitis. Using the
TDF to explore factors influencing the uptake of
evidence-based care of adults with minor traumatic
brain injury in the ED setting, then developing interven-
tion components to address these factors has previously
been undertaken in Australia [33]. We will use this ap-
proach for the design of interventions to promote
evidence-based practice in bronchiolitis care, which will
be evaluated in a cluster randomised controlled trial in
both the ED and paediatric inpatient setting in Australia
and New Zealand [37].
Although this study has clear strengths such as using a
theoretical framework to explore factors believed to in-
fluence practice as well as sound interview techniques
and rigorous coding to check interrater correlation,
there are inevitably potential limitations. Findings report
only the perceptions of those clinicians who participated.
However, we are reassured that saturation was reached
after 20 interviews, especially as clinicians had a wide
variety of experience, practice type and location, and,
suggest their views are likely to reflect the wider group
of clinicians managing bronchiolitis in Australia and
New Zealand. Due to the challenges of conducting inter-
views in two countries, there were slightly fewer Austra-
lian participants. We are aware that factors influencing
practice can change over time. The interviews were
completed during the period when the Australasian
Bronchiolitis Guideline [17] was being developed and
the effect that this may have had on practice across
Australia and New Zealand EDs and paediatric inpatient
areas cannot be underestimated.
Conclusion
Using the TDF, factors thought to influence the manage-
ment of infants with bronchiolitis in both ED and paedi-
atric inpatient areas have been identified. Each of the
interventions has its own pattern of influence but dem-
onstrates similarities across all with key factors relating
to beliefs about consequences, knowledge, social/profes-
sional role and identity, social influences and skills. Iden-
tification of these factors provides theoretically-derived
goals for the development of a KT intervention to ad-
dress the issues and measure effect and influence on
practice.
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